0001209191-23-040269.txt : 20230630
0001209191-23-040269.hdr.sgml : 20230630
20230630143429
ACCESSION NUMBER: 0001209191-23-040269
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230630
FILED AS OF DATE: 20230630
DATE AS OF CHANGE: 20230630
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sanders Corazon (Corsee) D.
CENTRAL INDEX KEY: 0001796536
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36276
FILM NUMBER: 231061138
MAIL ADDRESS:
STREET 1: C/O MOLECULAR TEMPLATES, INC.
STREET 2: 9301 AMBERGLEN BLVD, SUITE 100
CITY: AUSTIN
STATE: VI
ZIP: 78729
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ultragenyx Pharmaceutical Inc.
CENTRAL INDEX KEY: 0001515673
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 272546083
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 60 LEVERONI COURT
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 415-483-8800
MAIL ADDRESS:
STREET 1: 60 LEVERONI COURT
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-30
0
0001515673
Ultragenyx Pharmaceutical Inc.
RARE
0001796536
Sanders Corazon (Corsee) D.
C/O ULTRAGENYX PHARMACEUTICAL INC.
60 LEVERONI COURT
NOVATO
CA
94949
1
0
0
0
0
Common Stock
2023-06-30
4
S
0
585
46.76
D
8985
D
The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person prior to February 27, 2023.
/s/ Karah Parschauer, attorney-in-fact
2023-06-30